Менеджер по продажам 3D-оборудования в США

Описание

Curative Labs Inc
430 S Cataract Ave
San Dimas, CA 91773
support@curative.com
Final Results Report
Patient Name: Starostin, Sergey Facility: City of Seattle
Patient MRN: CUR138563237 Requisition: 50166043
Date of Birth: 1985-08-18 (36 years old) Kit ID: A943948339342
Sex: male Collected: 12/16/21 10:13:30 AM PST
Address: 525 NE Northgate W ay Seattle, WA 98125 Received: 12/17/21 03:56:01 PM PST
Phone Number: 12062292297 Released: 12/17/21 09:58:02 PM PST
Email: allthethings0000@gmail.com Specimen Type: Alinity shallow nasal swab
Physician: Zalzala, Sajad (1639311509)
Test Result
SARS-CoV -2 Assay (RNA Detection T est by RT-qPCR) Negative
Interpretation:
Positive: SARS-CoV -2 RNA detected by R T-qPCR
Negative: SARS-CoV -2 RNA not detected by R T-qPCR
Indeterminate: Indeterminate for SARS-CoV -2 RNA by RT-qPCR.
Positive results are indicative of the presence of SARS-CoV -2 RNA; clinical correlation with patient history and other diagnostic information is necessary
to dete rmine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be
the definite cause of disease. Laboratories within the United States and its territories are required to report all positive results to the appropriate public
health authorities.
Negative results do not preclude SARS-CoV -2 infection and should not be used as the sole basis for patient management decisions. Inadequate sample
collection or exposure to extreme heat during transport may decrease the ability to detect SARS-C oV-2 RNA in a sample. Negative results must be
combined with clinical observations, patient history , and epidemiological information.
Indeterminate results means that the test was not able to clearly determine whether SARS-CoV-2 was or was not present and may occur in the case of an
inadequate specimen. Specimen must be recollected if test is still required.
Method: Real-Time Reverse-Transcription PCR
This test is based on the CDC SARS-CoV -2 assay , a real-time reverse-transcription polymerase chain reaction (RT-PCR) test that detects RNA from
SARS-CoV -2 in upper or lower respiratory specimens. The test has been optimized to be performed on the BioRad CFX Real-T ime PCR detection system
and uses high throughput technologies.
Disclaimer:
This SARS-CoV -2 PCR test was developed and its performance characteristics were determined by Curative Labs. This test has not been cleared,
approved or authorized by the U.S. Food and Drug Administration (FDA). This test may be use d for clinical purposes and should not be regarded as
investigational or for research only. Cur ative Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) as qualified to
perform high complexity clinical laboratory testing. The results are not intended to be used as the sole means for clinical diagnosis or patient management
decisions.
Lab director : Arthur Baca MD, PhD; CLIA # 05D2141174; Sample reviewed at: 12/17/21 09:28:02 PM PST ; Report generated at: 12/17/21 10:00:11 PM
PST